XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Business Segments
 6 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280. Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.

The tables below summarize information about our reportable segments.
 Three Months Ended September 30, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$251,728 $24,497 $276,225 
Cost of sales108,623 9,890 118,513 
Gross profit143,105 14,607 157,712 
Advertising and marketing36,493 4,237 40,730 
Contribution margin$106,612 $10,370 116,982 
Other operating expenses 38,424 
Operating income $78,558 
* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.


 Six Months Ended September 30, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$494,121 $51,285 $545,406 
Cost of sales208,027 20,655 228,682 
Gross profit286,094 30,630 316,724 
Advertising and marketing71,723 8,446 80,169 
Contribution margin$214,371 $22,184 236,555 
Other operating expenses 66,655 
Operating income $169,900 
* Intersegment revenues of $1.7 million were eliminated from the North American OTC Healthcare segment.
 Three Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$216,575 $20,847 $237,422 
Cost of sales91,069 8,692 99,761 
Gross profit 125,506 12,155 137,661 
Advertising and marketing34,014 4,327 38,341 
Contribution margin$91,492 $7,828 99,320 
Other operating expenses 26,417 
Operating income $72,903 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.

 Six Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$427,233 $39,583 $466,816 
Cost of sales178,896 16,391 195,287 
Gross profit 248,337 23,192 271,529 
Advertising and marketing58,694 7,397 66,091 
Contribution margin$189,643 $15,795 205,438 
Other operating expenses 52,416 
Operating income $153,022 
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.


The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended September 30, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$29,943 $396 $30,339 
Cough & Cold23,022 5,006 28,028 
Women's Health65,020 3,345 68,365 
Gastrointestinal37,964 8,641 46,605 
Eye & Ear Care37,818 2,988 40,806 
Dermatologicals32,365 839 33,204 
Oral Care22,893 3,278 26,171 
Other OTC2,703 4 2,707 
Total segment revenues$251,728 $24,497 $276,225 
Six Months Ended September 30, 2021
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$62,764 $802 $63,566 
Cough & Cold37,067 9,853 46,920 
Women's Health128,268 7,289 135,557 
Gastrointestinal80,330 18,845 99,175 
Eye & Ear Care73,805 6,446 80,251 
Dermatologicals63,515 1,778 65,293 
Oral Care43,860 6,267 50,127 
Other OTC4,512 5 4,517 
Total segment revenues$494,121 $51,285 $545,406 


Three Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$30,623 $267 $30,890 
Cough & Cold14,796 3,086 17,882 
Women's Health61,492 4,106 65,598 
Gastrointestinal31,718 6,379 38,097 
Eye & Ear Care26,767 3,037 29,804 
Dermatologicals27,875 836 28,711 
Oral Care21,944 3,134 25,078 
Other OTC1,360 2 1,362 
Total segment revenues$216,575 $20,847 $237,422 

Six Months Ended September 30, 2020
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$58,490 $541 $59,031 
Cough & Cold28,234 6,988 35,222 
Women's Health126,902 6,537 133,439 
Gastrointestinal61,768 12,084 73,852 
Eye & Ear Care49,619 5,582 55,201 
Dermatologicals55,495 1,535 57,030 
Oral Care44,110 6,313 50,423 
Other OTC2,615 3 2,618 
Total segment revenues$427,233 $39,583 $466,816 

Our total segment revenues by geographic area are as follows:
Three Months Ended September 30, Six Months Ended September 30,
2021202020212020
United States$236,151 $203,289 $462,818 $402,635 
Rest of world40,074 34,133 82,588 64,181 
Total$276,225 $237,422 $545,406 $466,816 
Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows:
September 30, 2021North American OTC
Healthcare		International OTC
Healthcare		Consolidated
(In thousands)
Goodwill$548,401 $30,396 $578,797 
Intangible assets 
Indefinite-lived2,399,717 81,873 2,481,590 
Finite-lived, net205,267 3,063 208,330 
Intangible assets, net2,604,984 84,936 2,689,920 
Total$3,153,385 $115,332 $3,268,717 
March 31, 2021North American OTC
Healthcare		International OTC
Healthcare		Consolidated
(In thousands)
Goodwill$546,643 $31,436 $578,079 
Intangible assets 
Indefinite-lived2,195,617 86,371 2,281,988 
Finite-lived, net190,462 3,279 193,741 
Intangible assets, net2,386,079 89,650 2,475,729 
Total$2,932,722 $121,086 $3,053,808